KLA vs Lam Research KLAC vs LRCX
KLA and Lam Research on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.
What differs most
- Debt / equity: KLA 1.0×, Lam Research 0.4×.
- One-year price return: Lam Research +85.4%, KLA +50.8%.
- Consensus revenue growth for next year: Lam Research +50.7%, KLA +33.9%.
- Market value: Lam Research $330.30B, KLA $216.29B.
Price return
2025-10-16 → 2026-10-16
KLAC+50.8%
LRCX+85.4%
Profile
latestSector
Technology
Technology
Industry
Semiconductors
Semiconductors
Market value
$216.29B
$330.30B
Enterprise value
$220.39B
$329.28B
Employees
17,100
23,300
Revenue per employee (TTM)
$794K
$997K
Our models
nightlythe valuation on each stock's pagePrice vs model
103% overvalued vs model
147% overvalued vs model
Model range
$58.90–132
$81.36–158
Models in the headline
1
1
FCF growth priced in, at a 10% return
29.9%
32.7%
Every model, its assumptions and its range: KLAC valuation · LRCX valuation. The growth priced in, at any return: KLAC reverse DCF · LRCX reverse DCF.
Trading
close 2026-10-16Last close
$165.74
$263.94
52-week high
$301.71
$433.33
52-week low
$109.71
$139.59
Price vs 52-week high
−45.1%
−39.1%
Price vs 52-week low
+51.1%
+89.1%
Average daily volume / shares
1.0%
0.8%
Beta
1.45
1.85
Returns
to 2026-10-161 month
−1.0%
−2.0%
3 months
−24.4%
−17.8%
6 months
−4.5%
+1.1%
Year to date
+36.4%
+54.2%
1 year
+50.8%
+85.4%
1 year, dividends added
+51.6%
+86.2%
2 years
+142.8%
+256.0%
Valuation
price × FY2026P/E (TTM)
45.3×
45.8×
P/E on consensus EPS (next FY)
30.0×
27.7×
Price / sales
15.9×
14.2×
EV / sales
16.2×
14.2×
EV / EBITDA
—
38.1×
Price / book
37.1×
31.2×
Price / free cash flow (FY)
57.4×
67.5×
Free-cash-flow yield (FY)
1.7%
1.5%
Growth
TTM and FY2026Revenue growth (TTM)
+3.7%
+7.2%
Revenue growth, consensus next FY
+33.9%
+50.7%
Revenue, 3-year CAGR
9.0%
10.1%
Revenue, 5-year CAGR
14.4%
9.7%
EPS growth (TTM)
+3.7%
+8.9%
EPS growth, consensus next FY
+50.8%
+65.4%
EPS, 3-year CAGR
14.9%
20.1%
Free cash flow, 3-year CAGR
4.2%
1.5%
Diluted shares, 3-year change
−5.9%
−7.2%
Profitability
FY2026Gross margin (FY)†
61.3%
50.5%
Operating margin
—
35.3%
EBITDA margin
—
37.2%
Net margin
35.6%
31.3%
Free-cash-flow margin (FY)
27.7%
21.1%
Return on equity
82.9%
68.6%
Return on assets
28.6%
34.9%
Asset turnover
0.80
1.12
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.
Balance sheet
MRQ Mar 2026Cash
$1.79B
$4.75B
Total debt
$5.89B
$3.73B
Net debt
$4.10B
−$1.02B
Debt / equity
1.0×
0.4×
Net debt / EBITDA (TTM)
—
-0.1×
Interest coverage (FY)
19.9×
0.0×
Current ratio (FY)
2.88
2.63
Dividends
trailing 12 monthsDividend yield
0.5%
0.4%
Dividends per share
$0.84
$1.11
Payout ratio (of TTM EPS)
23.0%
19.3%
Dividend per share, 5-year CAGR
17.5%
15.5%
Frequency
Quarterly
Quarterly
Ownership and activity
last 90 days · latest 13FTracked superinvestors holding (13F)
4
9
Insider open-market buys (Form 4)
$0
$0
Insider sales (Form 4)
$60.7M
$40.5M
Analyst upgrades
0
0
Analyst downgrades
0
0
Statements
income FY2026 · cash flow FY2026Revenue
$13.58B
$23.23B
EBITDA
—
$8.64B
Operating income
—
$8.20B
Net income
$4.83B
$7.27B
EPS (diluted)
$3.66
$5.76
Operating cash flow
$4.14B
$5.86B
Capital expenditure
−$375.9M
−$966.4M
Free cash flow
$3.77B
$4.89B
Dividends paid
$1.06B
$1.27B
Statements from the companies' SEC filings; prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.